The potential role of genes in nonalcoholic fatty liver disease

Clinics in Liver Disease
C P Day

Abstract

Although most people with obesity and type 2 diabetes will have steatosis, only a minority will ever develop nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis. Family studies suggest that genetic factors are important in disease progression, although dissecting genetic factors playing a role in NASH and fibrosis from those influencing the development established risk factors is difficult. Several approaches can be used to look for genetic factors playing a role in nonalcoholic fatty liver disease (NAFLD). In the future, genome-wide single nucleotide polymorphism (SNP) scanning of cases and controls may become feasible. To date, however,studies have relied on candidate gene, case control, allele association methodology. Recent, and as yet preliminary, studies have reported associations between steatosis severity, NASH, and fibrosis with genes whose products are involved in lipid metabolism,oxidative stress, and endotoxin-cytokine interactions. If confirmed,these associations will enhance understanding of disease pathogenesis,and accordingly, the ability to design effective therapies.

References

Nov 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·I R Wanless, J S Lentz
Sep 13, 1996·Science·N Risch, K Merikangas
Mar 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·S Q YangA M Diehl
Apr 26, 1997·Lancet·I J BujalskaP M Stewart
Apr 16, 1998·American Journal of Human Genetics·R S Spielman, W J Ewens
Jun 10, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·C P Day, O F James
Sep 2, 1999·Human Molecular Genetics·M J JusticeA Bradley
Nov 24, 1999·BMJ : British Medical Journal·R C LinB J Morris
Jul 25, 2000·Journal of the National Cancer Institute·S WacholderN Caporaso
Nov 4, 2000·The American Journal of Medicine·V M StrubenS H Caldwell
Nov 30, 2000·The Journal of Biological Chemistry·Y LeeR H Unger
Mar 10, 2001·Nature·R SachidanandamUNKNOWN International SNP Map Working Group
Apr 26, 2001·Proceedings of the National Academy of Sciences of the United States of America·S C LuJ M Mato
May 9, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H A JärveläinenK O Lindros
Oct 5, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·V ParadisP Bedossa
Oct 5, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H YoshijiH Fukui
Dec 12, 2001·British Journal of Clinical Pharmacology·A K Daly, C P Day
Mar 27, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Michael CharltonK Sreekumaran Nair
May 8, 2002·The Journal of Clinical Investigation·Jay D HortonMichael S Brown
Jun 8, 2002·Pharmacogenomics·Richard JudsonJ Claiborne Stephens
Jun 18, 2002·Nature Medicine·Norikazu MaedaYuji Matsuzawa
Jul 13, 2002·Science·Paul CohenJeffrey M Friedman
Jul 27, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Matthew A WozniakUNKNOWN Trent HCV Study Group
Feb 25, 2003·Lancet·John P A IoannidisDespina G Contopoulos-Ioannidis
Feb 26, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ramón BatallerDavid A Brenner
Feb 28, 2003·Pharmacogenomics·Ann K Daly
Mar 19, 2003·Lancet·Helen M ColhounGeorge Davey Smith
Apr 2, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Giovanni MussoGianfranco Pagano
Apr 2, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Giulio MarchesiniMario Rizzetto
May 30, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Pouneh MofradArun J Sanyal
Jun 13, 2003·Nature·Toshimasa YamauchiTakashi Kadowaki
Jun 28, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Emilia IpIsabelle Leclercq
Jun 28, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Raghavakaimal SreekumarMichael Charlton
Jun 9, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Paola LoriaNicola Carulli

❮ Previous
Next ❯

Citations

Mar 28, 2008·The Korean Journal of Hepatology·Sang Hoon Park
Oct 13, 2009·Clinics in Liver Disease·Mangesh PagadalaArthur J McCullough
Feb 12, 2009·Gastroenterology·Jeffrey B SchwimmerClaude B Sirlin
Jun 5, 2007·Clinics in Liver Disease·John Edmison, Arthur J McCullough
Apr 21, 2007·Journal of Hepatology·Antonello PietrangeloBruce R Bacon
Feb 27, 2007·Translational Research : the Journal of Laboratory and Clinical Medicine·Luca MieleAntonio Grieco
Nov 5, 2005·Alimentary Pharmacology & Therapeutics·H ReynaertJ Henrion
Oct 18, 2005·Alimentary Pharmacology & Therapeutics·P LoriaN Carulli
Jan 30, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ralf Weiskirchen, Hermann E Wasmuth
May 26, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jiansheng HuangLi Wang
Nov 30, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Brian D Juran, Konstantinos N Lazaridis
Dec 24, 2010·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Helge BrunsPeter Schemmer
Apr 17, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Rohit LoombaUNKNOWN Nonalcoholic Steatohepatitis Clinical Research Network
Jan 13, 2006·Gastroenterology·Christopher Paul Day
Nov 9, 2005·Journal of Hepatology·Helena Cortez-PintoChristopher Paul Day
Nov 15, 2005·Endocrine Journal·Chao Chun ZouZheng Yan Zhao
Feb 4, 2005·The Journal of Clinical Investigation·Ramón Bataller, David A Brenner
Mar 9, 2007·Orvosi hetilap·Krisztina Hagymási, Zsolt Tulassay
Dec 12, 2013·Molecular Metabolism·Melanie KahleSusanne Neschen
Oct 11, 2011·Toxicology and Applied Pharmacology·Min TanGavin E Arteel
Apr 7, 2012·Arquivos De Gastroenterologia·Mônica Rodrigues de Araújo SouzaMaria Salete Trigueiro de Araújo
May 31, 2008·The American Journal of Gastroenterology·Kiran Bambha, Hal F Yee
Jan 27, 2007·Journal of Pediatric Gastroenterology and Nutrition·Rubén E Quirós-TejeiraNancy F Butte
Sep 20, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Takeshi ShimamuraRaj K Puri
Mar 1, 2010·Expert Review of Endocrinology & Metabolism·J Michael Estep, Zobair M Younossi
Sep 9, 2005·World Journal of Gastroenterology : WJG·Hiroki OikawaTomoyuki Masuda

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Z M YounossiVikas Chandhoke
The Journal of Biological Chemistry
Varman T SamuelGerald I Shulman
Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Jeffrey D BrowningHelen H Hobbs
© 2021 Meta ULC. All rights reserved